JANET BARNES: Open Payments
NPI 1669174777 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,638 in 144 payments from 29 companies in 2025. Trend: 2023 $91 · 2024 $2,723 · 2025 $3,638
Food & beverage: $2,976Travel & lodging: $585Education: $77
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $816 |
| ABBVIE INC. | 20 | $384 |
| PFIZER INC. | 26 | $292 |
| UCB, Inc. | 9 | $271 |
| Novartis Pharmaceuticals Corporation | 8 | $235 |
| Janssen Biotech, Inc. | 5 | $220 |
| EMD Serono, Inc. | 17 | $178 |
| Biogen, Inc. | 8 | $169 |
| Merz Pharmaceuticals, LLC | 5 | $126 |
| ARGENX US, INC. | 6 | $114 |
Products named: Vercise, NURTEC ODT, KESIMPTA, UBRELVY, Xeomin, VYVGART HYTRULO, TYSABRI, Nayzilam.
Industry payments across MO — which companies pay providers there.
